分析物
一致性
信息通信技术
生物传感器
电化学发光
量子点
假阳性率
免疫分析
灵敏度(控制系统)
甲胎蛋白
纳米技术
化学
检出限
色谱法
材料科学
计算机科学
医学
人工智能
肝细胞癌
免疫学
癌症研究
内科学
电子工程
抗体
工程类
信息和通信技术
万维网
作者
Qiuhua Yang,Xiaoqun Gong,Tao Song,Jiumin Yang,Sheng-Jiang Zhu,Yunhong Li,Cui Ye,Yingxin Li,Bingbo Zhang,Jin Chang
标识
DOI:10.1016/j.bios.2011.09.002
摘要
Rapid, quantitative detection of tumor markers with high sensitivity and specificity is critical to clinical diagnosis and treatment of cancer. We describe here a novel portable fluorescent biosensor that integrates quantum dot (QD) with an immunochromatography test strip (ICTS) and a home-made test strip reader for detection of tumor markers in human serum. Alpha fetoprotein (AFP), which is valuable for diagnosis of primary hepatic carcinoma, is used as a model tumor marker to demonstrate the performance of the proposed immunosensor. The principle of this sensor is on the basis of a sandwich immunoreaction that was performed on an ICTS. The fluorescence intensity of captured QD labels on the test line and control line served as signals was determined by the home-made test strip reader. The strong luminescence and robust photostability of QDs combined with the promising advantages of an ICTS and sensitive detection with the test strip reader result in good performance. Under optimal conditions, this biosensor is capable of detecting as low as 1 ng/mL AFP standard analyte in 10 min with only 50 μL sample volume. Furthermore, 1000 clinical human serum samples were tested by both the QD-based ICTS and a commercial electrochemiluminescence immunoassay AFP kit simultaneously to estimate the sensitivity, specificity and concordance of the assays. Results showed high consistency except for 24 false positive cases (false positive rate 3.92%) and 17 false negative cases (false negative rate 4.38%); the error rate was 4.10% in all. This demonstrates that the QD-based ICTS is capable of rapid, sensitive, and quantitative detection of AFP and shows a great promise for point-of-care testing of other tumor markers.
科研通智能强力驱动
Strongly Powered by AbleSci AI